NASDAQ: PSKY 24.52%
Netflix Backs Out of the Warner Bros. Deal. 5 Reasons It's a Smart Move
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: EDSA 47.03%
$38M Defense Backlog vs. $6M Market Cap, Breakthrough Biotech Data, and the Quantum Security Land Grab
NASDAQ: PRAA 32.17%
PRA Group (PRAA) Q4 2025 Earnings Call Transcript
NASDAQ: BWIN 28.55%
Baldwin (BWIN) Q4 2025 Earnings Call Transcript
NASDAQ: PSKY 31.15%
NASDAQ: ACXIF 31.15%
NASDAQ: EDSA 31.15%
NASDAQ: PRAA 31.15%
